106 related articles for article (PubMed ID: 1981505)
1. Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes.
Fuhr U; Wolff T; Harder S; Schymanski P; Staib AH
Drug Metab Dispos; 1990; 18(6):1005-10. PubMed ID: 1981505
[TBL] [Abstract][Full Text] [Related]
2. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
3. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
4. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
5. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.
Berthou F; Flinois JP; Ratanasavanh D; Beaune P; Riche C; Guillouzo A
Drug Metab Dispos; 1991; 19(3):561-7. PubMed ID: 1680620
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Campbell ME; Grant DM; Inaba T; Kalow W
Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
[TBL] [Abstract][Full Text] [Related]
8. Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2.
Kinzig-Schippers M; Fuhr U; Zaigler M; Dammeyer J; Rüsing G; Labedzki A; Bulitta J; Sörgel F
Clin Pharmacol Ther; 1999 Mar; 65(3):262-74. PubMed ID: 10096258
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
Harder S; Fuhr U; Staib AH; Wolff T
Am J Med; 1989 Nov; 87(5A):89S-91S. PubMed ID: 2589393
[TBL] [Abstract][Full Text] [Related]
10. Selective in-vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorufin and caffeine as model substrates.
Valero F; de la Torre R; Segura J
J Pharm Pharmacol; 1991 Jan; 43(1):17-21. PubMed ID: 1676053
[TBL] [Abstract][Full Text] [Related]
11. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
Fischer V; Vickers AE; Heitz F; Mahadevan S; Baldeck JP; Minery P; Tynes R
Drug Metab Dispos; 1994; 22(2):269-74. PubMed ID: 8013282
[TBL] [Abstract][Full Text] [Related]
12. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
Meredith CG; Maldonado AL; Speeg KV
Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomes.
Kim M; Shen DD; Eddy AC; Nelson WL; Roskos LK
Drug Metab Dispos; 1993; 21(2):309-17. PubMed ID: 8097702
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
16. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
17. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
Fuhr U; Anders EM; Mahr G; Sörgel F; Staib AH
Antimicrob Agents Chemother; 1992 May; 36(5):942-8. PubMed ID: 1510417
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
20. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
